One Day Med

Szczecin 70-419

3 studies enrolling now · 3 studies all time

What they study most

Anaplastic Lymphoma Kinase-positive, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Non-small Cell Lung Cancer

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now